In the past two decades, with the growing understanding of the orexin system’s role, particularly in regulating wakefulness, ORAs have shown significant potential as a new type of neurological or psychiatric drug for treating insomnia, making them a hot topic in drug research [71, 72]. This evidence concerns the gene HCRT and insomnia measurement.